AstraZeneca stock falls as investors balk at reported Bristol Myers tie-up
AstraZeneca shares dropped as much as 7% on Monday after reports that the company had discussed a potential…
By mid-2027, analysts expect £6,000 in GSK shares to be worth…
After a major move higher in the second half of 2025 and early 2026, GSK (LSE: GSK) shares…
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
JNJ and AZN Face Patent Headwinds: Which Stock Looks Stronger Now?
Johnson & Johnson JNJ and AstraZeneca AZN are among the largest global drugmakers, each supported by a diversified healthcare…
Trial Set in NEC Multidistrict Litigation Against Reckitt Benckiser’s Mead Johnson Led by Levin Papantonio
LONDON & PENSACOLA, Fla., March 05, 2026–(BUSINESS WIRE)–Reckitt Benckiser (LON: RKT) subsidiary Mead Johnson is facing a bellwether…
Global Oral Care Market Outlook 2026-2036: Daily Replenishment Demand and Premiumization Drive Growth for Colgate-Palmolive, Procter & Gamble, and Unilever
NEWARK, Del., May 19, 2026 /PRNewswire/ — According to the latest market analysis by Future Market Insights (FMI),…